Proteomics market shows rapid growth

The proteomics market grew from $1.1 billion in 2001 to almost $1.4 billion in 2002 and, according to a new report by Select Biosciences of Sudbury, England, the growth rate is continuing in 2003.

Prepared in San Francisco , California by Dr Steven Bodovitz, Proteomics 2003 presents a detailed market model and thorough analysis of the technologies and business strategies of 75 leading proteomics companies.  Proteomics 2003 projects that the market will grow to more than $ 2.5 billion by 2008, a compound annual growth rate of more than 14%.

Proteomics 2003 is based on extensive primary and secondary research, including interviews with company representatives.  It discusses the background of the three main market applications :

-Drug Target /Biomarker discovery and validation

-Drug development

-Clincal trials and Diagnostics

It provides in-depth information on the market, size segmented by technology and application.

In addition to a detailed market model, Proteomics 2003 evaluates the strengths and weaknesses of each of the proteomics vendors, and assesses both opportunities and threats facing their products & services. Proteomics 2003 identifies the companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward. 

Select Biosciences Ltd., is a strategic consulting firm that specializes in emerging markets and technologies in biotechnology and pharmaceuticals. Including several leading authorities, our consultants prepare business analyses and reviews, and have presented work at many biomedical conferences.

Click the title to order Proteomics 2003

http://www.bioportfolio.com/cgi-bin/acatalog/select_bioscience.html